Literature DB >> 29776986

The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis.

Jiajing Qiu1, Mohamed E Salama2, Cing Siang Hu1, Yan Li1, Xiaoli Wang1, Ronald Hoffman1.   

Abstract

The CD34-CD8α+, sinusoid lining, littoral cells (LCs), and CD34+CD8α-, splenic vascular endothelial cells (SVECs) represent 2 distinct cellular types that line the vessels within normal spleens and those of patients with myelofibrosis (MF). To further understand the respective roles of LCs and SVECs, each was purified from normal and MF spleens, cultured, and characterized. Gene expression profiling indicated that LCs were a specialized type of SVEC. LCs possessed a distinct gene expression profile associated with cytoskeleton regulation, cellular interactions, endocytosis, and iron transport. LCs also were characterized by strong phagocytic activity, less robust tube-forming capacity and a limited proliferative potential. These characteristics underlie the role of LCs as cellular filters and scavengers. Although normal LCs and SVECs produced overlapping as well as distinct hematopoietic factors and adhesion molecules, the gene expression profile of MF LCs and SVECs distinguished them from their normal counterparts. MF SVECs were characterized by activated interferon signaling and cell cycle progression pathways and increased vascular endothelial growth factor receptor, angiopoietin-2, stem cell factor, interleukin (IL)-33, Notch ligands, and IL-15 transcripts. In contrast, the transcription profile of MF LCs was associated with mitochondrial dysfunction, reduced energy production, protein biosynthesis, and catabolism. Normal SVECs formed in vitro confluent cell layers that supported MF hematopoietic colony formation to a greater extent than normal colony formation. These data provide an explanation for the reduced density of LCs observed within MF spleens and indicate the role of SVECs in the development of extramedullary hematopoiesis in MF.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2018        PMID: 29776986      PMCID: PMC5965045          DOI: 10.1182/bloodadvances.2017015073

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  49 in total

1.  Open source clustering software.

Authors:  M J L de Hoon; S Imoto; J Nolan; S Miyano
Journal:  Bioinformatics       Date:  2004-02-10       Impact factor: 6.937

Review 2.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  Structure and function of the spleen.

Authors:  Reina E Mebius; Georg Kraal
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

4.  Staining of human splenic sinusoids and demonstration of unusual banded structures by monoclonal antisera.

Authors:  A E Stuart; A Warford
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

Review 5.  Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.

Authors:  Ruben A Mesa; Giovanni Barosi; Francisco Cervantes; John T Reilly; Ayalew Tefferi
Journal:  Best Pract Res Clin Haematol       Date:  2006       Impact factor: 3.020

Review 6.  Embryonic development of the human hematopoietic system.

Authors:  Manuela Tavian; Bruno Péault
Journal:  Int J Dev Biol       Date:  2005       Impact factor: 2.203

7.  Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.

Authors:  Ayalew Tefferi; Rakhee Vaidya; Domenica Caramazza; Christy Finke; Terra Lasho; Animesh Pardanani
Journal:  J Clin Oncol       Date:  2011-02-07       Impact factor: 44.544

8.  Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration.

Authors:  Daniel J Nolan; Michael Ginsberg; Edo Israely; Brisa Palikuqi; Michael G Poulos; Daylon James; Bi-Sen Ding; William Schachterle; Ying Liu; Zev Rosenwaks; Jason M Butler; Jenny Xiang; Arash Rafii; Koji Shido; Sina Y Rabbany; Olivier Elemento; Shahin Rafii
Journal:  Dev Cell       Date:  2013-07-18       Impact factor: 12.270

9.  Homeostatic and pathogenic extramedullary hematopoiesis.

Authors:  Chang H Kim
Journal:  J Blood Med       Date:  2010-03-23

10.  A perisinusoidal niche for extramedullary haematopoiesis in the spleen.

Authors:  Christopher N Inra; Bo O Zhou; Melih Acar; Malea M Murphy; James Richardson; Zhiyu Zhao; Sean J Morrison
Journal:  Nature       Date:  2015-11-16       Impact factor: 49.962

View more
  6 in total

1.  The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen.

Authors:  Laura L Swystun; Kenichi Ogiwara; Jesse D Lai; Juha R M Ojala; Orla Rawley; Fanny Lassalle; Colleen Notley; Olle Rengby; Alison Michels; Kate Nesbitt; Karl Tryggvason; David Lillicrap
Journal:  J Thromb Haemost       Date:  2019-06-20       Impact factor: 5.824

Review 2.  Cellular reservoirs of latent cytomegaloviruses.

Authors:  Matthias J Reddehase; Niels A W Lemmermann
Journal:  Med Microbiol Immunol       Date:  2019-04-22       Impact factor: 3.402

Review 3.  Anatomical structures, cell types and biomarkers of the Human Reference Atlas.

Authors:  Katy Börner; Sarah A Teichmann; Ellen M Quardokus; James C Gee; Kristen Browne; David Osumi-Sutherland; Bruce W Herr; Andreas Bueckle; Hrishikesh Paul; Muzlifah Haniffa; Laura Jardine; Amy Bernard; Song-Lin Ding; Jeremy A Miller; Shin Lin; Marc K Halushka; Avinash Boppana; Teri A Longacre; John Hickey; Yiing Lin; M Todd Valerius; Yongqun He; Gloria Pryhuber; Xin Sun; Marda Jorgensen; Andrea J Radtke; Clive Wasserfall; Fiona Ginty; Jonhan Ho; Joel Sunshine; Rebecca T Beuschel; Maigan Brusko; Sujin Lee; Rajeev Malhotra; Sanjay Jain; Griffin Weber
Journal:  Nat Cell Biol       Date:  2021-11-08       Impact factor: 28.824

Review 4.  Novel targets to cure primary myelofibrosis from studies on Gata1low mice.

Authors:  Maria Zingariello; Fabrizio Martelli; Paola Verachi; Claudio Bardelli; Francesca Gobbo; Maria Mazzarini; Anna Rita Migliaccio
Journal:  IUBMB Life       Date:  2019-11-21       Impact factor: 3.885

Review 5.  Modern management of splenomegaly in patients with myelofibrosis.

Authors:  Douglas Tremblay; Myron Schwartz; Richard Bakst; Rahul Patel; Thomas Schiano; Marina Kremyanskaya; Ronald Hoffman; John Mascarenhas
Journal:  Ann Hematol       Date:  2020-05-17       Impact factor: 3.673

6.  KRasG12D expression in the bone marrow vascular niche affects hematopoiesis with inflammatory signals.

Authors:  Cindy L Hochstetler; Yuxin Feng; Mehmet Sacma; Ashley K Davis; Mahil Rao; Chia-Yi Kuan; Li-Ru You; Hartmut Geiger; Yi Zheng
Journal:  Exp Hematol       Date:  2019-10-24       Impact factor: 3.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.